BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27113335)

  • 1. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
    Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
    PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.
    Kesselring S; Osborne C; Bever A; Salters K; Cui Z; Chia J; Moore DM; Parashar S; Kaida A; Samji H; Duddy J; Gabler K; Howard T; Nash D; McCandless LC; Patterson TL; Corneil T; Montaner JSG; Hogg RS
    AIDS Care; 2019 Jul; 31(7):885-892. PubMed ID: 30466303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
    Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
    J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    BMC Infect Dis; 2018 Jan; 18(1):59. PubMed ID: 29378523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
    Kiertiburanakul S; Boettiger D; Lee MP; Omar SF; Tanuma J; Ng OT; Durier N; Phanuphak P; Ditangco R; Chaiwarith R; Kantipong P; Lee CK; Mustafa M; Saphonn V; Ratanasuwan W; Merati TP; Kumarasamy N; Wong WW; Zhang F; Pham TT; Pujari S; Choi JY; Yunihastuti E; Sungkanuparph S; ;
    J Int AIDS Soc; 2014; 17(1):18804. PubMed ID: 24598459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological distress, health and treatment-related factors among individuals initiating ART in Oromia, Ethiopia.
    Parcesepe AM; Tymejczyk O; Remien R; Gadisa T; Kulkarni SG; Hoffman S; Melaku Z; Elul B; Nash D
    AIDS Care; 2018 Mar; 30(3):338-342. PubMed ID: 28820273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
    Abdu M; Ali Y; Anteneh S; Yesuf M; Birhanu A; Mohamed S; Hussien A
    PLoS One; 2021; 16(3):e0248490. PubMed ID: 33724992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men.
    Liu Y; Ruan Y; Vermund SH; Osborn CY; Wu P; Jia Y; Shao Y; Qian HZ
    BMC Infect Dis; 2015 Dec; 15():570. PubMed ID: 26714889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection.
    Patel MR; Nana M; Yotebieng M; Tabala M; Behets F; Van Rie A
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):694-9. PubMed ID: 24903941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
    Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
    J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.
    Mehraj V; Cox J; Lebouché B; Costiniuk C; Cao W; Li T; Ponte R; Thomas R; Szabo J; Baril JG; Trottier B; Côté P; LeBlanc R; Bruneau J; Tremblay C; Routy JP;
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29412520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
    Lahuerta M; Wu Y; Hoffman S; Elul B; Kulkarni SG; Remien RH; Nuwagaba-Biribonwoha H; El-Sadr W; Nash D; ;
    Clin Infect Dis; 2014 Feb; 58(3):432-41. PubMed ID: 24198226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.